Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers

ClinicalTrials.gov ID: NCT06182358

Public ClinicalTrials.gov record NCT06182358. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Controlled Trial to Evaluate the Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the efficacy of XDEMVY ophthalmic drop to its vehicle control for the treatment of Demodex blepharitis and its impact on the soft contact lens wearing experience.

Study identification

NCT ID
NCT06182358
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Tarsus Pharmaceuticals, Inc.
Industry
Enrollment
145 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 27, 2023 (Actual)
Primary completion
Jan 27, 2025 (Actual)
Completion
Jan 27, 2025 (Actual)
Last update posted
Jul 2, 2025

2023 – 2025

United States locations

U.S. sites
14
U.S. states
14
U.S. cities
14
Facility City State ZIP Site status
Site Cave Creek Arizona 85331 —
Site Long Beach California 90805 —
Vision Institute Colorado Springs Colorado 80907 —
Site Delray Beach Florida 33484 —
Site Indianapolis Indiana 46240 —
Site Pittsburg Kansas 66762 —
Site Louisville Kentucky 40206 —
Site Edina Minnesota 55436 —
Site Shelby North Carolina 28150 —
Site Fargo North Dakota 58103 —
Site Powell Ohio 43065 —
Site Cranberry Township Pennsylvania 16066 —
Site Memphis Tennessee 38104 —
Site Houston Texas 77005 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06182358, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2025 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06182358 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →